Industry: Pharma & Healthcare
Published Date: 2025-03-28
Pages: 139 Pages
Report ld: 4675631
Request Sample
Customized Report
Human Prothrombin Complex Market Size(US$)

CAGR 2025-2031
11.8%
Market Size,2031
USD 4,251
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Prothrombin Complex in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Prothrombin Complex sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Prothrombin Complex Product Introduction
1.2 Market by Type
1.2.1 Global Human Prothrombin Complex Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Prothrombin Complex Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Prothrombin Complex Market Size Estimates and Forecasts
2.1.1 Global Human Prothrombin Complex Revenue 2020-2031
2.1.2 Global Human Prothrombin Complex Sales 2020-2031
2.2 Human Prothrombin Complex Market Size by Region: 2024 Versus 2031
2.3 Human Prothrombin Complex Sales by Region (2020-2031)
2.3.1 Global Human Prothrombin Complex Sales by Region: 2020-2025
2.3.2 Global Human Prothrombin Complex Sales Forecast by Region (2026-2031)
2.3.3 Global Human Prothrombin Complex Sales Market Share by Region (2020-2031)
2.4 Human Prothrombin Complex Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Prothrombin Complex Revenue by Region: 2020-2025
2.4.2 Global Human Prothrombin Complex Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Prothrombin Complex Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Prothrombin Complex Sales by Type (2020-2031)
3.1.1.1 Global Human Prothrombin Complex Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Prothrombin Complex Sales Market Share by Type (2020-2031)
3.1.2 Global Human Prothrombin Complex Revenue by Type (2020-2031)
3.1.2.1 Global Human Prothrombin Complex Revenue by Type (2020-2031)
3.1.2.2 Global Human Prothrombin Complex Revenue Market Share by Type (2020-2031)
3.1.3 Human Prothrombin Complex Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Prothrombin Complex Sales by Application (2020-2031)
3.2.1.1 Global Human Prothrombin Complex Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Prothrombin Complex Sales Market Share by Application (2020-2031)
3.2.2 Global Human Prothrombin Complex Revenue by Application (2020-2031)
3.2.2.1 Global Human Prothrombin Complex Revenue by Application (2020-2031)
3.2.2.2 Global Human Prothrombin Complex Revenue Market Share by Application (2020-2031)
3.2.3 Human Prothrombin Complex Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 500 IU/Vial of Human Prothrombin Complex Revenue Market Share by Application
3.3.2 600 IU/Vial of Human Prothrombin Complex Revenue Market Share by Application
3.3.3 1000 IU/Vial of Human Prothrombin Complex Revenue Market Share by Application
3.3.4 Others of Human Prothrombin Complex Revenue Market Share by Application
4 Global Human Prothrombin Complex by Manufacturers
4.1 Global Top Human Prothrombin Complex Manufacturers by Sales (2020-2025)
4.1.1 Global Human Prothrombin Complex Sales by Manufacturer (2020-2025)
4.1.2 Global Human Prothrombin Complex Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Prothrombin Complex Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Prothrombin Complex Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Prothrombin Complex Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Prothrombin Complex Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Prothrombin Complex Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Prothrombin Complex Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Prothrombin Complex Manufacturing Base Distribution, Product Type
4.5.1 Human Prothrombin Complex Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Prothrombin Complex Market
4.5.3 Manufacturers Human Prothrombin Complex Product Type and Application
4.5.4 500 IU/Vial Market Sales of Human Prothrombin Complex by Manufacturer
4.5.5 600 IU/Vial Market Sales of Human Prothrombin Complex by Manufacturer
4.5.6 1000 IU/Vial Market Sales of Human Prothrombin Complex by Manufacturer
4.5.7 Others Market Sales of Human Prothrombin Complex by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Takeda
5.1.1 Takeda Company Information
5.1.2 Takeda Description, Business Overview
5.1.3 Takeda Human Prothrombin Complex Products Offered
5.1.4 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Takeda Human Prothrombin Complex Sales by Product in 2024
5.1.6 Takeda Human Prothrombin Complex Sales by Application in 2024
5.1.7 Takeda Human Prothrombin Complex Sales by Geographic Area in 2024
5.1.8 Takeda Recent Developments
5.2 CSL
5.2.1 CSL Company Information
5.2.2 CSL Description, Business Overview
5.2.3 CSL Human Prothrombin Complex Products Offered
5.2.4 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.2.5 CSL Human Prothrombin Complex Sales by Product in 2024
5.2.6 CSL Human Prothrombin Complex Sales by Application in 2024
5.2.7 CSL Human Prothrombin Complex Sales by Geographic Area in 2024
5.2.8 CSL Recent Developments
5.3 Grifols
5.3.1 Grifols Company Information
5.3.2 Grifols Description, Business Overview
5.3.3 Grifols Human Prothrombin Complex Products Offered
5.3.4 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Grifols Human Prothrombin Complex Sales by Product in 2024
5.3.6 Grifols Human Prothrombin Complex Sales by Application in 2024
5.3.7 Grifols Human Prothrombin Complex Sales by Geographic Area in 2024
5.3.8 Grifols Recent Developments
5.4 Octapharma
5.4.1 Octapharma Company Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Human Prothrombin Complex Products Offered
5.4.4 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Human Prothrombin Complex Sales by Product in 2024
5.4.6 Octapharma Human Prothrombin Complex Sales by Application in 2024
5.4.7 Octapharma Human Prothrombin Complex Sales by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Hualan Biological
5.5.1 Hualan Biological Company Information
5.5.2 Hualan Biological Description, Business Overview
5.5.3 Hualan Biological Human Prothrombin Complex Products Offered
5.5.4 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hualan Biological Human Prothrombin Complex Sales by Product in 2024
5.5.6 Hualan Biological Human Prothrombin Complex Sales by Application in 2024
5.5.7 Hualan Biological Human Prothrombin Complex Sales by Geographic Area in 2024
5.5.8 Hualan Biological Recent Developments
5.6 Meheco Xinxing Pharma
5.6.1 Meheco Xinxing Pharma Company Information
5.6.2 Meheco Xinxing Pharma Description, Business Overview
5.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
5.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Product in 2024
5.6.6 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Application in 2024
5.6.7 Meheco Xinxing Pharma Human Prothrombin Complex Sales by Geographic Area in 2024
5.6.8 Meheco Xinxing Pharma Recent Developments
6 North America
6.1 North America Human Prothrombin Complex Market Size YoY Growth 2020-2031
6.2 North America Human Prothrombin Complex Market Facts & Figures by Country
6.2.1 North America Human Prothrombin Complex Sales by Country (2020-2031)
6.2.2 North America Human Prothrombin Complex Revenue by Country (2020-2031)
6.3 North America Human Prothrombin Complex Sales by Type (2020-2025)
6.4 North America Human Prothrombin Complex Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Prothrombin Complex Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Prothrombin Complex Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Prothrombin Complex Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Prothrombin Complex Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Prothrombin Complex Sales by Type (2020-2025)
7.4 Asia-Pacific Human Prothrombin Complex Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Prothrombin Complex Market Size YoY Growth 2020-2031
8.2 Europe Human Prothrombin Complex Market Facts & Figures by Country
8.2.1 Europe Human Prothrombin Complex Sales by Country (2020-2031)
8.2.2 Europe Human Prothrombin Complex Revenue by Country (2020-2031)
8.3 Europe Human Prothrombin Complex Sales by Type (2020-2025)
8.4 Europe Human Prothrombin Complex Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Prothrombin Complex Market Size YoY Growth 2020-2031
9.2 Latin America Human Prothrombin Complex Market Facts & Figures by Country
9.2.1 Latin America Human Prothrombin Complex Sales by Country (2020-2031)
9.2.2 Latin America Human Prothrombin Complex Revenue by Country (2020-2031)
9.3 Latin America Human Prothrombin Complex Sales by Type (2020-2025)
9.4 Latin America Human Prothrombin Complex Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Prothrombin Complex Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Prothrombin Complex Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Prothrombin Complex Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Prothrombin Complex Sales by Type (2020-2025)
10.4 Middle East and Africa Human Prothrombin Complex Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Prothrombin Complex Supply Chain Analysis
11.2 Human Prothrombin Complex Key Raw Materials and Upstream Suppliers
11.3 Human Prothrombin Complex Clients Analysis
11.4 Human Prothrombin Complex Sales Channel and Sales Model Analysis
11.4.1 Human Prothrombin Complex Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Prothrombin Complex Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Prothrombin Complex Distributors
12 Human Prothrombin Complex Market Dynamics
12.1 Human Prothrombin Complex Industry Trends
12.2 Human Prothrombin Complex Market Drivers
12.3 Human Prothrombin Complex Market Challenges
12.4 Human Prothrombin Complex Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now